Clinical Trial Detail

NCT ID NCT01684397
Title Pazopanib Hydrochloride and Bevacizumab in Treating Patients With Previously Untreated Metastatic Kidney Cancer
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Roswell Park Cancer Institute
Indications

clear cell renal cell carcinoma

Therapies

Bevacizumab + Pazopanib

Age Groups: adult

No variant requirements are available.